Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 1818885-28-7
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
ARV-825 is a potent, selective inhibitor of the BCL-XL protein, designed to disrupt protein-protein interactions critical in apoptosis regulation. This compound features a stabilized macrocyclic scaffold that enhances target affinity and cellular penetration. It demonstrates robust activity in tumor models reliant on BCL-XL survival signaling, offering a valuable tool for cancer research and therapeutic development.
ARV-825 serves as a potent, selective inhibitor of the IAP family of proteins, specifically targeting survivin and BIRC6. It functions as a covalent antagonist by engaging the E3 ligase complex through its thiol-reactive warhead, enabling targeted ubiquitination and proteasomal degradation of anti-apoptotic proteins. This mechanism facilitates apoptosis in cancer cells with high dependency on IAPs, offering a validated approach for overcoming resistance in solid tumors. Its stability under physiological conditions supports consistent performance in cell-based assays and preclinical models.
|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: